Get the Stockscreener App
159.27
1.50%
-2.42
Overview
News
Price History
Option Chain
Financials
Why ZTS Down?
Discussions
Forecast
Dividend History
Zoetis Inc stock is traded at $159.27, with a volume of 4.24M.
It is down -1.50% in the last 24 hours and up +3.73% over the past month.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
See More
Previous Close:
$161.69
Open:
$161.41
24h Volume:
4.24M
Relative Volume:
1.38
Market Cap:
$70.23B
Revenue:
$9.29B
Net Income/Loss:
$2.52B
P/E Ratio:
28.59
EPS:
5.57
Net Cash Flow:
$2.28B
1W Performance:
+1.16%
1M Performance:
+3.73%
6M Performance:
-9.93%
1Y Performance:
-5.27%
1-Day Range:
$159.08
$162.44
1-Week Range:
$148.99
$162.44
52-Week Range:
$139.70
$200.33
Zoetis Inc Stock (ZTS) Company Profile
Compare ZTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
159.27 | 70.23B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.74 | 48.23B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.36 | 48.22B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.93 | 18.57B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.42 | 13.29B | 2.76B | 1.11B | 898.10M | 22.77 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-12-24 | Reiterated | Stifel | Buy |
| Dec-19-23 | Resumed | Jefferies | Buy |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-08-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-08-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-21-20 | Initiated | Atlantic Equities | Overweight |
| Aug-14-20 | Upgrade | Edward Jones | Hold → Buy |
| Aug-12-20 | Downgrade | Gabelli & Co | Buy → Hold |
| May-27-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Sep-09-19 | Initiated | Goldman | Buy |
| Jul-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-11-19 | Initiated | Barclays | Overweight |
| May-23-19 | Initiated | Guggenheim | Buy |
| May-03-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-04-19 | Upgrade | Stifel | Hold → Buy |
| Jan-23-19 | Initiated | UBS | Neutral |
| Oct-15-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-22-18 | Downgrade | Stifel | Buy → Hold |
| Aug-03-18 | Reiterated | Stifel | Buy |
| Apr-19-18 | Reiterated | Citigroup | Buy |
| Mar-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-16-18 | Reiterated | Stifel | Buy |
| Jan-04-18 | Upgrade | Citigroup | Neutral → Buy |
View All
Zoetis Inc Stock (ZTS) Latest News
Centiva Capital LP Makes New $1.09 Million Investment in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Banque Transatlantique SA Makes New $79.04 Million Investment in Zoetis Inc. (NYSE:ZTS) - MarketBeat
BNP Paribas Exane Adjusts Price Target on Zoetis to $226 From $219, Keeps Outperform Rating - marketscreener.com
Zoetis' Q1: Market Overreaction Or Justified Drop? (NYSE:ZTS) - Seeking Alpha
Brevan Howard Capital Management LP Decreases Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Acquired by Bokf Na - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Purchased by Eagle Global Advisors LLC - MarketBeat
EP Wealth Advisors LLC Buys 4,498 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (ZTS): Among Paul Tudor Jones’ Stock Picks with Huge Upside Potential - Insider Monkey
Zoetis Inc. (NYSE:ZTS) Shares Acquired by Captrust Financial Advisors - MarketBeat
Aptus Capital Advisors LLC Increases Stock Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Bought by Alpha Family Trust - MarketBeat
Veterinary Healthcare Market Generated Opportunities, Future - openPR.com
Alteri Wealth LLC Buys New Shares in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Bellevue Group AG Purchases 4,495 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
277,650 Shares in Zoetis Inc. (NYSE:ZTS) Purchased by BLI Banque de Luxembourg Investments - MarketBeat
Brown Advisory Inc. Sells 235,296 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Veterinary Vaccines Market Size, Share & Trends Analysis Report 2025-2032|Zoetis Inc.,Merck & Co., Inc - openPR.com
Zoetis: Solid Q1 Results And A Weaker Dollar Provide Support (Upgrade) - Seeking Alpha
Axa S.A. Raises Stock Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc (ZTS) Trading 3.76% Higher on May 8 - GuruFocus
Zoetis (NYSE:ZTS) Posts Earnings Results, Beats Expectations By $0.08 EPS - MarketBeat
Zoetis (NYSE:ZTS) Releases FY 2025 Earnings Guidance - MarketBeat
Zoetis (ZTS) Faces Lowered Price Target Amid Product Concerns | - GuruFocus
Bridgefront Capital LLC Acquires New Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Bamco Inc. NY Cuts Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Mercer Global Advisors Inc. ADV Sells 3,129 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Veterinary Pathologist's Pay Bias Suit Teed Up For Trial - Law360
Zoetis Inc. (NYSE:ZTS) Stock Holdings Decreased by Meiji Yasuda Life Insurance Co - MarketBeat
Zoetis (NYSE:ZTS) Q1 Earnings Increase With Sales At US$2220 Million - simplywall.st
UBS cuts Zoetis stock price target to $170 from $189 By Investing.com - Investing.com Nigeria
FFAR, DMI & Zoetis Seek to Study Connection Between Dairy Cow Health, Economics & the Environment - Morning Ag Clips
Zoetis Q1 Earnings & Revenues Beat Estimates, '25 Outlook Raised - MSN
UBS cuts Zoetis stock price target to $170 from $189 - Investing.com
Zoetis, Female Veterinary Pathologist Headed for Equal Pay Trial - news.bloombergtax.com
UBS Lowers Price Target for Zoetis (ZTS) to $170, Maintains Neutral Rating | ZTS Stock News - GuruFocus
UBS Adjusts Price Target on Zoetis to $170 From $189, Maintains Neutral Rating - marketscreener.com
Zoetis Inc. (NYSE:ZTS) Q1 2025 Earnings Call Transcript - Insider Monkey
Leerink Adjusts Price Target on Zoetis to $180 From $190, Maintains Outperform Rating - marketscreener.com
Udder Health Market Key Players AnalysisVetoquinol S.A., - openPR.com
Zoetis (ZTS) Faces Lowered Price Target Amid Product Concerns | ZTS Stock News - GuruFocus
Cary Street Partners Financial LLC Invests $15.70 Million in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Chapman Financial Group LLC Takes $2.21 Million Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Baird Financial Group Inc. Has $75.22 Million Stock Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Bank of America Corp DE Sells 2,847,378 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Ameriprise Financial Inc. Raises Stake in Zoetis Inc. (NYSE:ZTS) - MarketBeat
AQR Capital Management LLC Has $47.85 Million Stake in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Lido Advisors LLC Has $3.32 Million Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Caisse DE Depot ET Placement DU Quebec Increases Stock Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc (ZTS) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid Competitive Pressures - Yahoo Finance
Zoetis Inc (ZTS) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid Competitive Pressures By GuruFocus - Investing.com Canada
Zoetis Inc Stock (ZTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
6.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):